The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma

BACKGROUND: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal prognosis due to chemo-resistance and immuno-compromised micro-environment. The combination of zidovudine and interferon-alpha (IFN) significantly improved survival in ATL. Promising results were reported by adding a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kchour, Ghada, Rezaee, SA Rahim, Farid, Reza, Ghantous, Akram, Rafatpanah, Houshang, Tarhini, Mahdi, Kooshyar, Mohamad-Mehdi, El Hajj, Hiba, Berry, Fadwa, Mortada, Mohamad, Nasser, Roudaina, Shirdel, Abbas, Dassouki, Zeina, Ezzedine, Mohamad, Rahimi, Hossein, Ghavamzadeh, Ardeshir, de Thé, Hugues, Hermine, Olivier, Mahmoudi, Mahmoud, Bazarbachi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751834/
https://www.ncbi.nlm.nih.gov/pubmed/23962110
http://dx.doi.org/10.1186/1742-4690-10-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751834/
https://www.ncbi.nlm.nih.gov/pubmed/23962110
http://dx.doi.org/10.1186/1742-4690-10-91

Ejemplares similares